Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
Meta Expands AI Training With Employee Activity Tracking Tools 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
DENVER, May 24, 2017 -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen M. Deitsch, Senior Vice President, Chief Financial Officer and Treasurer will present at the Jefferies 2017 Global Healthcare Conference on Wednesday, June 7, 2017, at 4:00 p.m. EDT.
A live webcast of the presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://www.bioscrip.com/investors or through the following link http://wsw.com/webcast/jeff105/bios.
About BioScrip
BioScrip, Inc. is a leading national provider of infusion and home care management solutions. BioScrip partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Investor Contacts: Stephen Deitsch Chief Financial Officer & Treasurer T: (720) 697-5200 [email protected] David Clair ICR, Inc. T: (646) 277-1266 [email protected]
